Kayser, Sabine, and Richard F. Schlenk. 2026. “All Patients With AML and FLT3-ITD Should Be Transplanted in First Remission. Also in the Era of Tyrosine Kinase Inhibitors? – the PRO”. Haematologica 111 (4). Pavia, Italy, 1149-52. https://doi.org/10.3324/haematol.2025.288785.